USPTO serial 88770805
ARGORNA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 8, 2022
- Examiner
- BATT, JAIME L
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ARGORNA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
ARGORNA PHARMACEUTICALS LIMITED
HUANGPU DISTRICT, GUANGZHOU, CN
ARGORNA PHARMACEUTICALS LIMITED
HUANGPU DISTRICT, GUANGZHOU, CN
Guangzhou, Guangdong, CN
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Stacy L. Emhoff
Stacy L. Emhoff WALKER & JOCKE CO., LPA231 SOUTH BROADWAYMEDINA, OH 44256UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicines for human purposes for the treatment of tumor, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; Pharmaceutical preparations for the treatment of tumor, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; Chemical-pharmaceutical preparations for the treatment of tumor, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; Drug delivery agents in the form of sterile liquid, sterile freeze-dry powder, emulsion or inhalation for medical purposes that provide controlled release of active ingredients for the treatment of tumor, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; Veterinary preparations for the treatment of bird flu, porcine reproductive and respiratory syndrome, rabies, distemper, and heartworm in cats, dogs, horses, chicken and pigs; Medicines for veterinary purposes being preparations for the treatment of bird flu, porcine reproductive and respiratory syndrome, rabies, distemper, and heartworm in cats, dogs, horses, chicken and pigs; Biological preparations for veterinary purposes for the treatment of bird flu, porcine reproductive and respiratory syndrome, rabies, distemper, and heartworm; Chemical preparations for veterinary purposes for the treatment of bird flu, porcine reproductive and respiratory syndrome, rabies, distemper, and heartworm; Preparations for destroying noxious animals, namely, pesticides, insecticides; Preparations for destroying noxious plants, namely, herbicides | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ARGORNA PHARMACEUTICALS LIMITED
- Other trademarks owned by ARGORNA PHARMACEUTICALS LIMITED
- Other trademarks owned by GUANGZHOU RIBOBIO CO., LTD.
- Other trademarks in Class 005
- Similar marks named ARGORNA
- Prosecution event R.PR explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 8, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 21, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 21, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 1, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 23, 2021 | OTHE | CASE RETURNED TO EXAMINATION | — |
| Sep 23, 2021 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Sep 23, 2021 | PCBG | PETITION TO DIRECTOR - CHANGE BASIS - GRANTED | — |
| Sep 20, 2021 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Sep 14, 2021 | APET | ASSIGNED TO PETITION STAFF | — |
| Sep 7, 2021 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Sep 7, 2021 | TPAD | TEAS PETITION TO AMEND BASIS RECEIVED | — |
| Jul 29, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 27, 2021 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jul 27, 2021 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jul 27, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 12, 2021 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jan 27, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 25, 2021 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jan 25, 2021 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jan 25, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 12, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 4, 2020 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 9, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 9, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 20, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 29, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 20, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 20, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 20, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 20, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 13, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 27, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 27, 2020 | NWAP | NEW APPLICATION ENTERED | — |